"10.1371_journal.pone.0055149","plos one","2013-02-01T00:00:00Z","Jens O Watzlawik; Arthur E Warrington; Moses Rodriguez","Departments of Neurology and Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America","Conceived and designed the experiments: JOW AEW MR. Performed the experiments: JOW AEW. Analyzed the data: JOW AEW. Contributed reagents/materials/analysis tools: MR. Wrote the paper: JOW AEW MR.","rHIgM22 antibody has been licensed to Acorda Therapeutics by the Mayo Foundation. Mayo Clinic owns the patent for the enhancement of remyelination in MS by rHIgM22. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials as long as these do not conflict with the applicable Mayo terms located on the following page: www.mayo.edu/copyright/.","2013","02","Jens O Watzlawik","JOW",3,TRUE,3,2,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
